Rachel Presti, MD, PhD uses ICTS resources for COVID-19 research and clinical trial efforts
The CTSA program was developed to accelerate new treatments from the lab to patients, enabled to a large extent by patients participating in and benefiting from clinical trials. Clinical trials provide that needed bridge from human subjects to hypotheses to treatments that can directly benefit human health. And, never has this connection been more critical […]
COVID-19 dual-antibody therapies effective against variants in animal study (Links to an external site)
COVID-19 therapies made from antibodies often are given to patients who are at high risk of severe illness and hospitalization. However, there have been nagging questions about whether such antibody therapies retain their effectiveness as worrisome new virus variants arise.
LMtV Podcast: examining SARS-CoV-2 colonization of the maternal-fetal interface
How does COVID-19 impact pregnancy? ‘Let’s Meet the Virologists’, hosted by Larissa Thackray, PhD, associate professor of Infectious Diseases, talks in Episode 28 with Sonam Verma, PhD, a postdoctoral research associate in the Mysorekar laboratory in the Center for Reproductive Health Sciences, about her work examining SARS-CoV-2 colonization of the placenta, the impact on the […]
Jeff Henderson, MD, PhD lead author of study that shows blood cancer patients with COVID-19 fare better with convalescent plasma (Links to an external site)
Retrospective study also indicates outcomes of critically ill patients in ICU improve when given antibodies from recovered COVID-19 patients A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalized with the virus.
COVID-19 vaccine generates immune structures critical for lasting immunity – ID clinical researchers, Presti and O’Halloran collaboration with pathology & immunology researchers, Ellebedy and Turner (Links to an external site)
Vaccines likely induce strong, persistent immunity to COVID9
Congratulations to our class of 2021 graduating fellows!
We are so proud of this graduating class of fellows. Their achievements are many and mentioned below in a brief synopsis of each fellow. Miguel Chavez, MD, MSc is the recipient of the 2021 SHEA Jonathan Freeman Scholarship Award, has published 2 peer reviewed articles, and presented 3 posters (healthcare epidemiology, microbiology, fungal infection and […]
LMtV Podcast: Let’s ‘meet’ the clinical epidemiologist Dr. Ziyad Al-Aly examining the acute and long-term burden of COVID19 disease.
What are the potential long-term effects of COVID-19? ‘Let’s Meet the Virologists’, hosted by Larissa Thackray, PhD, associate professor of Infectious Diseases, talks in Episode 29 withZiyad Al-Aly, MD, FASN, assistant professor in the Division of General Medical Services, Director of the Clinical Epidemiology Center, and Chief of Research and Education Service at the VA […]
Gayaythri Krishnan, MD chosen as Chief ID Fellow for FY 2022
Dr. Krishnan was selected by her ID fellow peers to serve as the second Chief ID Fellow. She follow Nathan Nolan, MD and recent graduate of the ID Fellowhip program . Honored, humbled and ecstatic about this new responsibility, Gayathry hopes to promote Fellow wellness and trainee education. “Thank you @WashUID for entrusting me with […]
Mild COVID-19 induces lasting antibody protection (Links to an external site)
Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all the while.
Podcast: What to make of CDC’s new masking guidelines
The latest episode of the “Show Me the Science” podcast focuses on the CDC’s new masking guidelines. Guest William G. Powderly, MD, the Larry J. Shapiro Director of the Institute for Public Health and co-director of the Division of Infectious Diseases at WashU Med, says the new guidelines provide evidence that, for many fully vaccinated […]
George Kyei, MD, PhD assistant professor of medicine, will discuss “HIV and COVID in Ghana” Monday, May10 at 1 pm (Links to an external site)
Global Health Work in Progress (GHWIP) aims to bring together members of the Washington University global health community to learn about each other’s work.
Washington University Clinical Trials Unit to participate in the first polyclonal antibody for treatment of COVID-19
ACTG Adds First Polyclonal Antibody to ACTIV-2 Outpatient Treatment Study for COVID-19 The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the addition SAB-185, a polyclonal antibody therapy, to the COVID-19 outpatient treatment study, ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial. ACTIV-2 includes both phase 2 and phase 3 […]
The ID Division celebrates the Drs. Gerald and Medoff Professorship in ID, held by Dr. Gary Weil
Gerald Medoff, MD, a physician scientist and one of the founding leaders of the Mycosis Study Group, was the ID Division Director for more than 20 years at Washington University School of Medicine (WUM). Dr. Medoff fostered the first WUSM AIDS Clinical Trials Unit, HIV clinic and HIV/AIDS Advocacy. He provided leadership and training for, […]
Zika virus helps destroy deadly brain cancer in mice – senior author, Mike Diamond, MD, PhD, co-first author Sharmila Nair, PhD (Links to an external site)
The Zika virus that ravaged the Americas, leaving many babies with permanent brain damage, may have a silver lining. The virus can activate immune cells to destroy an aggressive brain cancer in mice, giving a powerful boost to an immunotherapy drug and sparking long-lasting immunological memory that can ward off tumor recurrence for at least […]
LMtV Podcast: Let’s ‘meet’ the virologist Dr. Sebastien Felt who is studying defective viral genomes or DVGs and how they modulate the clinical outcome of respiratory syncytial virus (RSV), a significant cause of pediatric respiratory disease.
RSV infects most children before the age of two and leads to a wide range of disease outcomes from asymptomatic to severe. While host genetic factors for severe outcome are known, viral determinants are not as well defined. ‘Let’s Meet the Virologists’, hosted by Larissa Thackray, PhD, associate professor of Infectious Diseases, talks in Episode […]